Alpha Natural rated new Buy at Sterne Agee
ANR was initiated with a Buy rating, Sterne Agee said. $35 price target. Company remains leveraged to growth in the met coal market.
-----
Apple estimates, target increased at Morgan Stanley
AAPL estimates were raised through 2013, Morgan Stanley said. iPhone continues to drive growth. Overweight rating and new $480 price target.
-----
Apple estimates increased at UBS
AAPL estimates raised through 2013, UBS said. iPhone purchase and carrier launch delays ahead of 4S cause shortfall. Maintain $510 price target and Buy rating.
-----
Arch Coal rated new Neutral at Sterne Agee
Coverage of ACI was started with a Neutral rating, Sterne Agee said. $23 price target. Company faces integration challenges.
-----
Bank of America estimates lowered at Sterne Agee
BAC estimates were cut through 2013, Sterne Agee said. Company will take a while to turn its business around. Neutral rating and $7 price target.
-----
Bank of America numbers lowered at UBS
Shares of BAC now seen reaching $7, according to UBS. Estimates also lowered on weaker capital markets and lower reserve releases. Neutral rating.
-----
Chipotle Mexican Grill rated new Neutral at UBS
CMG was initiated with a Neutral rating, UBS said. $345 price target. Solid near term outlook, but appears appropriately valued.
-----
Citrix Systems upgraded at Needham
CTXS was upgraded from Hold to Buy, Needham said. $85 price target. Spending on data center projects should remain strong.
-----
Coca-Cola estimates lowered at Credit Suisse
KO estimates were cut through 2013, Credit Suisse said. Currency changes are cutting into earnings. Outperform rating and $95 price target.
-----
Coca-Cola numbers lowered at UBS
Shares of KO now seen reaching $73, according to UBS. Estimates also lowered on currency and spending impact. Maintain Buy rating.
-----
Cree estimates, target reduced at Sterne
Shares of CREE now seen reaching $52, according to Sterne Agee. Estimates also cut, to match the company's new guidance. Buy rating.
-----
Cree estimates, target lowered at UBS
Shares of CREE now seen reaching $29.50, according to UBS. Estimates also lowered as outlook suggest industry is still bottoming. Neutral rating.
-----
EMC estimates upped at Sterne Agee
EMC estimates were boosted through 2012, Sterne Agee said. Company is gaining market share and realizing higher margins. Buy rating and $30 price target.
-----
Forest Laboratories numbers reduced at Goldman
Shares of FRX now seen reaching $30, according to Goldman Sachs. Estimates also cut, given the company's negative operating leverage.
-----
Forest Labs estimates, target cut at UBS
Shares of FRX now seen reaching $32, according to UBS. Estimates also lowered on below guidance launches. Neutral rating.
-----
Fossil rated new Buy at Citigroup
FOSL was initiated with a Buy rating, Citigroup said. $114 price target. Strategic positions and minimal competition have yielded moderately priced watch market leadership.
-----
Goldman Sachs estimates reduced at ThinkEquity
GS estimates were cut through 2012, ThinkEquity said. Company will likely continue to see lower capital markets activity. Outperform rating and $181 price target.
-----
Goldman Sachs estimates, target cut at UBS
Shares of GS now seen reaching $140, according to UBS. Estimates also lowered on weaker expectations of capital markets activity. Buy rating.
-----
Grainger estimates, target raised at UBS
Shares of GWW now seen reaching $177, according to UBS. Estimates also increased on solid inflation management and growth initiatives gaining. Neutral rating.
-----
Harley-Davidson numbers cut at Goldman
Shares of HOG now seen reaching $44, according to Goldman Sachs. Estimates also reduced, given higher operating costs. Neutral rating.
-----
Harley-Davidson estimates cut at UBS
HOG estimates lowered through 2012, UBS said. Q3 margins miss and FY11 margin guidance revised down. Maintain $39 price target and Neutral rating.
-----
Hospira estimates, target cut at Citigroup
Shares of HOSP now seen reaching $30, according to Citigroup. Estimates also lowered on manufacturing issus at the Rocky Mount facility. Neutral rating.
-----
Human Genome numbers cut at ThinkEquity
Shares of HGSI now seen reaching $26, according to ThinkEquity. Estimates also reduced, given a modest Benlysta launch. Buy rating.
-----
Intel estimates, target raised at Citigroup
Shares of INTC now seen reaching $27.50, according to Citigroup. Estimates also increased as company is executing well, but market disparity a lingering concern. Buy rating.
-----
Intel estimates, target raised at Goldman
Shares of INTC now seen reaching $22, according to Goldman Sachs. Estimates also increased, as higher sales is driving margin expansion.
-----
Intel estimates, target raised at UBS
Shares of INTC now seen reaching $30, according to UBS. Estimates also increased as solid execution offsets macro weakness. Buy rating.
-----
Intuitive Surgical numbers boosted at Goldman
Sahres of ISRG now seen reaching $412, according to Goldman Sachs. Estimates also upped, to match the company's new guidance. Neutral rating.
-----
Juniper estimates, target cut at Credit Suisse
Shares of JNPR now seen reaching $25, according to Credit Suisse. Estimates also reduced, given the company's new guidance. Neutral rating.
-----
Juniper Networks estimates lowered at UBS
JNPR estimates cut through 2012, UBS said. Strong 3Q bookings and visibility better into 1Q, but still risk. Maintain $24 price target and Neutral rating.
-----
Juniper Networks downgraded at Wells
JNPR was downgraded from Outperform to Market Perform, Wells Fargo said. Growth outlook is deteriorating.
-----
Netflix estimates reduced at Credit Suisse
NFLX estimates were cut through 2013, Credit Suisse said. Company is realizing slower domestic subscriber growth. Outperform rating and $240 price target.
-----
Parker Hannifin numbers raised at Goldman
Shares of PH now seen reaching $81, according to Goldman Sachs. Estimates also increased, given better business momentum. Neutral rating.
-----
Rightnow Technologies downgraded at Stifel
RNOW was downgraded from Buy to Hold, Stifel Nicolaus said. Valuation call.
-----
Sotheby's rated new Neutral at Citigroup
BID was initiated with a Neutral rating, Citigroup said. $35 price target. High trust agency model with low inventory risk.
-----
State Street numbers increased at Goldman
STT estimates were raised through 2013, Goldman Sachs said. Company is gaining market share and keeping a tight lid on costs. Buy rating and new $48 price target.
-----
Steel Dynamics numbers lowered at Jefferies
STLD estimates were cut through 2012, Jefferies said. Company is leveraged to lower steel demand. Buy rating and new $16 price target.
-----
Steven Madden rated new Buy at Citigroup
SHOO was initiated with a Buy rating, Citigroup said. $41 price target. Accelerating sales/EPS despite economy.
-----
Under Armour numbers raised at Jefferies
Shares of UA now seen reaching $73, according to Jefferies. Estimates also increased, as the company should continue to expand margins. Buy rating.
-----
UnitedHealth estimates increased at Credit Suisse
UNH estimates were raised through 2012, Credit Suisse said. Company continues to deliver solid growth. Outperform rating and $72 price target.
-----
UnitedHealth Group estimates raised at UBS
UNH estimates increased through 2011, UBS said. Among best positioned to navigate uncertainties heading into 2014. Maintain $58 price target and Buy rating.
-----
US Steel rated new Market Perform at Wells
Coverage of X was started with a Market Perform rating, Wells Fargo said. Company continues to face macro headwinds.
-----
Vera Bradley rated new Buy at Citigroup
VRA was initiated with a Buy rating, Citigroup said. $51 price target. See sales upside on industry leading comparable same store sales.
-----
VF Corp. estimates raised at UBS
VFC estimates increased through 2012, UBS said. TBL, FX, and North Face upside. Maintain $135 price target and Buy rating.
-----
Whole Foods upgraded at Jefferies
WFM was upgraded to Buy, Jefferies said. $90 price target. Estimates also boosted, as the company continues to deliver comp sales growth.
-----
WW Grainger numbers upped at Goldman
GWW estimates were boosted through 2013, Goldman Sachs said. Company is realizing higher margins. Neutral rating and new $176 price target.
-----
Yahoo estimates upped at Credit Suisse
YHOO estimates were boosted through 2012, Credit Suisse said. Company is realizing higher margins. Neutral rating and $19 price target.
-----
Yahoo estimates increased at UBS
YHOO estimates raised through 2012, UBS said. Mixed quarter as investors remain focused on potential event. Maintain $16 price target and Neutral rating.
